Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-03-24 / Clin. Cancer Res. 2009 Apr;15(7):2531-40Immunotherapy of acute myeloid leukemia: current approaches
/in Acute Leukemia, International Publications /von 2009-03-16 / Oncologist 2009 Mar;14(3):240-52Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting
/in Dendritic Cells, International Publications /von 2009-03-11 / Blood 2009 May;113(21):5167-75Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium
/in Hyperthermia, International Publications /von 2009-03-11 / Cancer Chemother. Pharmacol. 2009 Nov;64(6):1079-83Coordination of intratumoral immune reaction and human colorectal cancer recurrence
/in Colorectal Cancer, International Publications /von 2009-03-03 / Cancer Res. 2009 Mar;69(6):2685-93Promising novel immunotherapies and combinations for prostate cancer
/in International Publications, Prostate Cancer /von 2009-03-01 / Future Oncol 2009 Mar;5(2):187-96Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer
/in International Publications, Pancreatic Cancer /von 2009-03-01 / Expert Opin Biol Ther 2009 Mar;9(3):331-9Genetically engineered Newcastle disease virus for malignant melanoma therapy
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2009-02-26 / Gene Ther. 2009 Jun;16(6):796-804Strong synergy of heat and modulated electromagnetic field in tumor cell killing
/in Hyperthermia, International Publications /von 2009-02-25 / Strahlenther Onkol 2009 Feb;185(2):120-6
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de